Patent ID: 8455464

Claim:
A method of reducing the incidence of non-post operative adhesions in or associated with a peritoneal cavity, the adhesions being formed as a result of an inflammatory response in the peritoneal cavity to an inflammatory response causative agent, the method comprising: (a) causing an inflammatory response in the peritoneal cavity as a result of a chemical insult or administration of an agent that can cause an inflammatory response; and (b) administering an aqueous formulation containing the polysaccharide dextrin into the peritoneal cavity, wherein the aqueous formulation is administered simultaneously with the inflammatory response causative agent and wherein the inflammatory response causative agent is selected from the group consisting of a chemotherapeutic agent, a gene therapy agent, an antibiotic agent and an antiviral agent and wherein the composition is allowed to remain in the peritoneal cavity for a minimum of 2 to 3 days.